Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials

To describe the effects of treatment for 1 year with ranibizumab or bevacizumab on macular morphology and the association of macular morphology with visual acuity (VA) in eyes with neovascular age-related macular degeneration (AMD). Prospective cohort study within a randomized clinical trial. Partic...

Full description

Saved in:

Bibliographic Details
Published in:	Ophthalmology (Rochester, Minn.) Vol. 120; no. 9; p. 1860
Main Authors:	Jaffe, Glenn J, Martin, Daniel F, Toth, Cynthia A, Daniel, Ebenezer, Maguire, Maureen G, Ying, Gui-Shuang, Grunwald, Juan E, Huang, Jiayan
Format:	Journal Article
Language:	English
Published:	United States 01.09.2013
Subjects:	Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Fluorescein Angiography Follow-Up Studies Humans Macula Lutea - pathology Macular Degeneration - diagnosis Macular Degeneration - drug therapy Macular Degeneration - physiopathology Prospective Studies Ranibizumab Subretinal Fluid Tomography, Optical Coherence Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity - physiology
ISSN:	1549-4713, 1549-4713
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!